EP1173479A4 - 49 human secreted proteins - Google Patents

49 human secreted proteins

Info

Publication number
EP1173479A4
EP1173479A4 EP00920163A EP00920163A EP1173479A4 EP 1173479 A4 EP1173479 A4 EP 1173479A4 EP 00920163 A EP00920163 A EP 00920163A EP 00920163 A EP00920163 A EP 00920163A EP 1173479 A4 EP1173479 A4 EP 1173479A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00920163A
Other languages
German (de)
French (fr)
Other versions
EP1173479A1 (en
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1173479A1 publication Critical patent/EP1173479A1/en
Publication of EP1173479A4 publication Critical patent/EP1173479A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00920163A 1999-04-09 2000-04-06 49 human secreted proteins Withdrawn EP1173479A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12869799P 1999-04-09 1999-04-09
US128697P 1999-04-09
US17692900P 2000-01-20 2000-01-20
US176929P 2000-01-20
PCT/US2000/009067 WO2000061627A1 (en) 1999-04-09 2000-04-06 49 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1173479A1 EP1173479A1 (en) 2002-01-23
EP1173479A4 true EP1173479A4 (en) 2002-11-20

Family

ID=26826857

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00920163A Withdrawn EP1173479A4 (en) 1999-04-09 2000-04-06 49 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1173479A4 (en)
JP (1) JP2003500019A (en)
AU (1) AU4074300A (en)
CA (1) CA2371223A1 (en)
WO (1) WO2000061627A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1213352A1 (en) * 2000-12-07 2002-06-12 Aventis Pharma S.A. Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
US10822380B2 (en) 2015-04-08 2020-11-03 University Of Georgia Research Foundation, Inc. Disruption of the WAVE3 protein complex for suppression of invasion and metastasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654139A (en) * 1994-09-21 1997-08-05 The United States Of America As Represented By The Department Of Health And Human Services Allelic variation of the serotonin 5HT2c receptor

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI, Hinxton, Cambridgeshire, UK; 15 June 1998 (1998-06-15), SULSTON & WATERSTON: "Homo sapiens PAC clone RP5-1173I20 from 7, complete sequence", XP002199611, Database accession no. AC004987 *
DATABASE EMBL [online] EBI, Hinxton, Cambridgeshire, UK; 17 March 2000 (2000-03-17), BAGGULEY, C.: "Human DNA sequence from clone RP5-997D24 on chromosome 1", XP002199607, Database accession no. AL161644 *
DATABASE EMBL [online] EBI, Hinxton, Cambridgeshire, UK; 3 September 1998 (1998-09-03), WOESSNER ET AL: "Homo sapiens full length cDNA clone YZ84E01", XP002199612, Database accession no. AF086085 *
DATABASE GENESEQ [online] EBI, Hinxton, Cambridgeshire, UK; 1 March 1999 (1999-03-01), BREWER ET AL: "Polypeptide encoded by Gene 70", XP002200187, Database accession no. AAW88831 *
DATABASE GENESEQ [online] EBI, Hinxton, Cambridgeshire, UK; 1 March 1999 (1999-03-01), BREWER ET AL: "Polypeptide encoded by gene 70", XP002200188, Database accession no. AAW88830 *
DATABASE GENESEQ [online] EBI, Hinxton, Cambridgeshire, UK; 15 February 2000 (2000-02-15), HILLMAN ET AL: "Human receptor molecule (REC) encoded by Incyte clone 2121924", XP002199605, Database accession no. AAY32202 *
DATABASE SWISSPROT [online] EBI, Hinxton, Cambridgeshire, UK; 1 February 1997 (1997-02-01), BAYARSAIHAN ET AL: "Single stranded DNA binding protein (SSDP) (CSDP) (FRAGMENT).", XP002199610, Database accession no. AAQ98948 *
See also references of WO0061627A1 *

Also Published As

Publication number Publication date
JP2003500019A (en) 2003-01-07
WO2000061627A1 (en) 2000-10-19
CA2371223A1 (en) 2000-10-19
EP1173479A1 (en) 2002-01-23
AU4074300A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
EP1218408A4 (en) 32 human secreted proteins
EP1212343A4 (en) 52 human secreted proteins
EP1181390A4 (en) 27 human secreted proteins
EP1224285A4 (en) 27 human secreted proteins
EP1212342A4 (en) 18 human secreted proteins
EP1226231A4 (en) 19 human secreted proteins
EP1175438A4 (en) 62 human secreted proteins
EP1192176A4 (en) 49 human secreted proteins
EP1192278A4 (en) 48 human secreted proteins
EP1175439A4 (en) 49 human secreted proteins
EP1165827A4 (en) 45 human secreted proteins
EP1159284A4 (en) 33 human secreted proteins
EP1189917A4 (en) 48 human secreted proteins
EP1185543A4 (en) 50 human secreted proteins
EP1224201A4 (en) 32 human secreted proteins
EP1173477A4 (en) 49 human secreted proteins
EP1203005A4 (en) 25 human secreted proteins
EP1206573A4 (en) 26 human secreted proteins
EP1171460A4 (en) 48 human secreted proteins
EP1144614A4 (en) 33 human secreted proteins
EP1169332A4 (en) 49 human secreted proteins
EP1165602A4 (en) 49 human secreted proteins
EP1165828A4 (en) 50 human secreted proteins
EP1185285A4 (en) 49 human secreted proteins
EP1228082A4 (en) 29 human secreted proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HUMAN GENOME SCIENCES, INC.

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/12 A, 7C 12N 5/10 B, 7C 07K 14/47 B, 7C 07K 16/18 B, 7C 12Q 1/68 B, 7G 01N 33/50 B, 7G 01N 33/68 B, 7A 61K 31/711 B, 7A 61K 38/12 B

A4 Supplementary search report drawn up and despatched

Effective date: 20021004

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20031006

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040417